Results 161 to 170 of about 106,790 (296)

Characteristics and toxicology of adult deaths due to quetiapine toxicity in Australia, 2000–2024

Journal of Forensic Sciences, EarlyView.
Abstract Quetiapine is an atypical antipsychotic that has been associated with both intentional and unintentional deaths. We aimed to determine, stratified by intentionality: (1) The characteristics and circumstances of adult deaths attributed solely to quetiapine toxicity in Australia, 2000–2024; (2) The blood toxicology of cases for quetiapine and ...
Shane Darke, Johan Duflou, Julia Lappin, Michael Farrell, Amy Peacock   +4 more
wiley   +1 more source

Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment Outcomes. [PDF]

Pharmaceuticals (Basel)
Varney L, Murtough S, Cotic M, Abidoph R, Chan L, Saadullah Khani N, Richards-Belle A, Richards-Brown M, Mills D, Panconesi D, Dawda Y, Sharma P, Shah C, Secchi A, Nilforooshan R, Mudholkar S, Murdoch R, Molai J, Griffiths R, Senthilkumar S, Blake H, Lankshear S, McRoberts J, Pastor B, Thomas C, Richards S, Welfare-Wilson A, Cheung SB, Cox R, Jibero AC, Anad R, Laczik R, Ghali S, Berry AJ, Curwen J, Odutoye K, Kottalgi G, Williams S, Wong S, Anandan N, Pius G, Ajiteru T, Clark V, van Driel P, Bashir A, Court S, Pawsey M, Skowronska A, Woodley J, Bramon E.   +49 more
europepmc   +1 more source

Effect of the GLP‐1 receptor agonist exenatide on pro‐inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double‐blinded, placebo‐controlled clinical trial

Alcohol, Clinical and Experimental Research, EarlyView.
This study compared pro‐inflammatory and metabolic biomarker profiles between individuals with alcohol use disorder (AUD) and those without, and evaluated the impact of the GLP‐1 receptor agonist exenatide on these biomarkers in the AUD group. At baseline, individuals with AUD exhibited significantly elevated levels of IL‐6, hsCRP, and FGF‐21, and ...
Malthe E. B. Hviid, Lea A. N. Christoffersen, Mette K. Klausen, Thorsten Brodersen, Ole B. Pedersen, Sisse R. Ostrowski, Margit H. Larsen, Mette Kongstad, Mathias E. Jensen, Tina Vilsbøll, Anders Fink‐Jensen   +10 more
wiley   +1 more source

Antipsychotic treatment adherence and motor vehicle crash among drivers with schizophrenia: a case-crossover study. [PDF]

CMAJ
Staples JA, Daly-Grafstein D, Khan M, Pei LX, Erdelyi S, Rezansoff SN, Chan H, Honer WG, Brubacher JR.   +8 more
europepmc   +1 more source

Antipsychotic Polypharmacy, Part 2: Tips on Use and Misuse

, 1999
Stephen M. Stahl
openalex   +2 more sources

Comparison of bodyweight gain with new antipsychotics [PDF]

, 1999
NULL AUTHOR_ID
openalex   +1 more source

Formulating Cognitive Functioning to Guide Personalised Treatment for People Diagnosed With Mental Disorders

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Objective and subjective cognitive impairment are highly prevalent in mental disorders and transdiagnostic phenomena. Cognitive impairment is associated with poorer functional outcomes and therefore requires treatment, but little guidance is available for clinicians.
Kelly Allott, Shayden Bryce, Katie Douglas, Alexandra Stainton, Stephen J. Wood, Christopher R. Bowie   +5 more
wiley   +1 more source

Childhood Maltreatment and Cognitive Functioning in Bipolar Disorder: A Systematic Review and Meta‐Analysis

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Aims Characterising the association between childhood maltreatment (CM) and cognitive functioning in bipolar disorder (BD) is crucial for improving the understanding of how early environmental risk factors impact the presentation of the disorder.
Natalia E. Fares‐Otero, Anaid Pérez‐Ramos, Ricardo Lopez‐Escribano, Sara Martin‐Parra, Luis Alameda, Sarah L. Halligan, Kamilla Woznica Miskowiak, Eduard Vieta   +7 more
wiley   +1 more source

Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort Study. [PDF]

Neurol Ther
Heald A, Tilston G, Warner-Levy JJ, Wilkins L, Williams R, Pillinger T, Deakin W, Longson D, Hassan L, Dalton C, Reynolds GP, Firth J.   +11 more
europepmc   +1 more source

Weight Gain and Antipsychotic Medications

, 1999
Ralph Aquila, Marianne Emanuel
openalex   +2 more sources